Oncology
We are deeply engaged in the oncology field, focusing on the research, development, and supply of high-quality treatment solutions for a broad range of solid tumors and hematologic malignancies. Our comprehensive product portfolio includes innovative anticancer drugs, targeted therapies, generics, and large molecules, covering chemotherapy, targeted therapy, etc.
Small molecule: Oxaliplatin, Pemetrexed and Gefitinib etc.
Monoclonal antibodies: trastuzumab, bevacizumab etc.